Thermo Fisher Scientific Share Price Börse Stuttgart
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
550.4 EUR | +0.46% | +2.83% | +14.17% |
Sales 2024 * | 43.01B 39.65B 3,589B | Sales 2025 * | 46.08B 42.48B 3,845B | Capitalization | 227B 209B 18,947B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.63B 510B | Net income 2025 * | 7B 6.45B 584B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 22.12B 2,002B | Net Debt 2025 * | 19.18B 17.69B 1,601B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | - |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 week | +2.83% | ||
Current month | +2.55% | ||
1 month | +3.59% | ||
3 months | +9.06% | ||
6 months | +29.71% | ||
Current year | +14.17% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Director of Finance/CFO | 57 | 01/01/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
C. Harris
BRD | Director/Board Member | 67 | 30/12/30 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01/22/01 |
Date | Price | Change |
---|---|---|
15/24/15 | 554 | +1.11% |
14/24/14 | 547.9 | +0.37% |
13/24/13 | 545.9 | +1.64% |
10/24/10 | 537.1 | +1.07% |
09/24/09 | 531.4 | -0.41% |
Delayed Quote Börse Stuttgart, May 15, 2024 at 07:23 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.82% | 192B | |
+16.82% | 136B | |
+28.95% | 108B | |
+1.18% | 64.07B | |
+17.15% | 52.1B | |
+6.74% | 51.87B | |
+10.03% | 44.33B | |
+4.90% | 36.75B | |
+27.34% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock